US 10350265
Therapeutic applications of Smad7
granted A61KA61K31/7088A61K38/00
Quick answer
US patent 10350265 (Therapeutic applications of Smad7) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/7088, A61K38/00, A61K38/162, A61K38/1709